Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Trends in the medical supply of fentanyl and fentanyl analogues: United States, 2006 to 2017.

Authors: Collins, Lacee K; Pande, Leana J; Chung, Daniel Y; Nichols, Stephanie D; McCall, Kenneth L; Piper, Brian J

Published In Prev Med, (2019 06)

Abstract: Fentanyl is an important opioid for pain management, but also has exceptional potential for misuse. Seven states have implemented opioid prescribing laws. The objectives of this study were to: 1) characterize the temporal pattern of fentanyl, fentanyl analogue, and other opioid use over the past decade, and 2) determine whether opioid prescribing laws impacted fentanyl use in the US. Drug weights were obtained from the US Automated Reports of Consolidated Orders System (June 2018), a comprehensive publically available resource, from 2006 to 2017 for fentanyl, sufentanil, remifentanil, alfentanil, other prescription opioids, and analyzed by presence of a state opioid prescribing law. Fentanyl, corrected for population, was reduced from 2016 to 2017 (-17.9%) and these decreases significantly exceeded the changes in hydrocodone (-12.3%), oxycodone (-10.1%), morphine (-13.3%), or codeine (-8.8%). Fentanyl showed a particularly large decline in Maine, a state with a strong opioid prescribing law. There was a 3.5 fold difference in fentanyl (μg per capita) in Alaska (488.2) relative to Oregon (1718.4). Hospital use of remifentanil and sufentanil tripled from 2006 to 2017. Although all states experienced a 2016 to 2017 decline in fentanyl, and this reduction was larger than many other prescription opioids, the rate of decline varied over three-fold between states. Strong state laws may account for a portion of the variance in fentanyl and other opioid reductions. The population health risks of fentanyl and fentanyl analogues warrants ongoing vigilance.

PubMed ID: 30763629 Exiting the NIEHS site

MeSH Terms: Adult; Aged; Aged, 80 and over; Alfentanil/supply & distribution*; Alfentanil/therapeutic use; Analgesics, Opioid/supply & distribution*; Analgesics, Opioid/therapeutic use; Female; Fentanyl/supply & distribution*; Fentanyl/therapeutic use*; Forecasting; Humans; Male; Middle Aged; Opioid-Related Disorders/epidemiology; Practice Patterns, Physicians'/trends*; Remifentanil/supply & distribution*; Remifentanil/therapeutic use; Sufentanil/supply & distribution*; Sufentanil/therapeutic use; United States/epidemiology

Back
to Top